Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Alogliptin
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alogliptin 25mg tablets
0601023AKAAACAC
|
Alogliptin | Alogliptin | Endocrine System | 296,337 |
|
Alogliptin 12.5mg tablets
0601023AKAAABAB
|
Alogliptin | Alogliptin | Endocrine System | 52,018 |
|
Alogliptin 6.25mg tablets
0601023AKAAAAAA
|
Alogliptin | Alogliptin | Endocrine System | 14,704 |
|
Vipidia 25mg tablets
0601023AKBBACAC
|
Vipidia | Alogliptin | Endocrine System | 2,787 |
|
Vipidia 12.5mg tablets
0601023AKBBABAB
|
Vipidia | Alogliptin | Endocrine System | 440 |
|
Vipidia 6.25mg tablets
0601023AKBBAAAA
|
Vipidia | Alogliptin | Endocrine System | 96 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.